Publications by authors named "Amy Burd"

Claim this Profile
mutation is associated with favorable outcome among older adults with newly diagnosed acute myeloid leukemia treated with hypomethylating agent-based therapy.
Fieke W Hoff, Ying Huang, Rina Li Welkie, Ronan T Swords, Elie Traer, Amy Burd

Haematologica· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 1b/2 Study of TP-0903 and Decitabine Targeting Mutant TP53 and/or Complex Karyotype in Patients with Untreated Acute Myeloid Leukemia ≥Age 60 Years.
Eric D Eisenmann, Ronan Swords, Ying Huang, Shelley Orwick, Daelynn Buelow, Amy Burd

Cancer Res Commun· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: a report from the Beat AML clinical trial.
Fieke W Hoff, Ying Huang, Rina Li Welkie, Ronan T Swords, Elie Traer, Amy Burd

Blood Cancer J· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beat-AML 2024 ELN-refined risk stratification for older adults with newly diagnosed AML given lower-intensity therapy.
Fieke W Hoff, William G Blum, Ying Huang, Rina Li Welkie, Ronan T Swords, Amy Burd

Blood Adv· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A study to assess the efficacy of enasidenib and risk-adapted addition of azacitidine in newly diagnosed IDH2-mutant AML.
Sheng F Cai, Ying Huang, Jennie R Lance, Hsiaoyin Charlene Mao, Andrew J Dunbar, Amy Burd

Blood Adv· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Samples from patients with AML show high concordance in detection of mutations by NGS at local institutions vs central laboratories.
Uma Borate, Fei Yang, Richard Press, Amy S Ruppert, Dan Jones, Amy Burd

Blood Adv· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world genomic testing and treatment patterns of newly diagnosed adult acute myeloid leukemia patients within a comprehensive health system.
John C Byrd, Jennifer L Gatz, Cynthia Lim Louis, Alice S Mims, Uma Borate, Amy Burd

Cancer Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Entospletinib with decitabine in acute myeloid leukemia with mutant TP53 or complex karyotype: A phase 2 substudy of the Beat AML Master Trial.
Vu H Duong, Amy S Ruppert, Alice S Mims, Uma Borate, Eytan M Stein, Amy Burd

Cancer· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pevonedistat with azacitidine in older patients with TP53-mutated AML: a phase 2 study with laboratory correlates.
Antoine N Saliba, Scott H Kaufmann, Eytan M Stein, Prapti A Patel, Maria R Baer, Amy Burd

Blood Adv· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance.
Junhua Lyu, Yuxuan Liu, Lihu Gong, Mingyi Chen, Yazan F Madanat, Amy Burd

Cancer Discov· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Streamlined Operational Approaches and Use of e-Technologies in Clinical Trials: Beat Acute Myeloid Leukemia Master Trial.
Len Rosenberg, Hugh Levaux, Ross L Levine, Amit Shah, James Denmark, Amy Burd

Ther Innov Regul Sci· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A precision medicine classification for treatment of acute myeloid leukemia in older patients.
Alice S Mims, Jessica Kohlschmidt, Uma Borate, James S Blachly, Shelley Orwick, Amy Burd

J Hematol Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master Trial.
Amy Burd, Ross L Levine, Amy S Ruppert, Alice S Mims, Uma Borate

Nat Med· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges and approaches to implementing master/basket trials in oncology.
Amy Burd, Richard L Schilsky, John C Byrd, Ross L Levine, Vassiliki A Papadimitrakopoulou

Blood Adv· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assembly of major histocompatibility complex (MHC) class II transcription factors: association and promoter recognition of RFX proteins.
Amy L Burd, Richard H Ingraham, Susan E Goldrick, Rachel R Kroe, James J Crute

Biochemistry· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis